Poland· PL-100327318
Accofil
A filgrastim product containing filgrastimum, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Filgrastim is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AA02 (filgrastim), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Filgrastim · ATC L03AA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Filgrastimum
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Poland (PL)
- ATC code
- L03AA02
- ATC class
- Filgrastim
- Defined daily dose
- 0.35 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
3 priced- gtin050555657138461 amp.-strzyk.PLN 68.25
- gtin050555657138605 amp.-strzyk.PLN 170.38
- gtin050555657260687 amp.-strz.PLN 239.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for filgrastim.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Filgrastim · interactions on record
191 records
- 2 severe
- 189 moderate
Most severe, free to view
- CladribineL01BB04severe
- CyclophosphamideL01AA01moderate
- ChlorambucilL01AA02moderate
- MelphalanL01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Filgrastim in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACCOFILAccord Healthcare S.L.U., Barcelona
- FinlandAccofilAbacus Medicine A/S
- United StatesFILKRIAccord BioPharma Inc.,
- SpainACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADAAccord Healthcare S.L.U.
- BelgiumAccofil 12 10*6 U/0.2 mlAccord Healthcare
- IrelandAccofil 30 MU/0.5 ml solution for injection/infusion in pre-filled syringeAccord Healthcare S.L.U.
- FranceACCOFIL 12 MU/0,2 ml, solution injectable ou pour perfusion en seringue préremplieACCORD HEALTHCARE (ESPAGNE)
- SwedenAccofil 12 ME/0,2 ml Injektions- / infusionsvätska, lösning i förfylld sprutaAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Neupogen
- Germany · Neupogen
- Spain · Neupogen
- France · Neupogen
- United Kingdom (Northern Ireland) · Neupogen, Neupogen Singleject
- Ireland · Neupogen, Neupogen Singleject
- Iceland · Accofil, Filgrastim Hexal
- Italy · Granulokine
- Liechtenstein · Accofil, Filgrastim Hexal
- Luxembourg · Neupogen
- Netherlands · Neupogen, Neupogen Singleject
- Norway · Accofil, Filgrastim Hexal
- Sweden · Neupogen
- Slovenia · Neupogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61d853dd-77c0-4215-b3ba-1c5149e470b5 GET /v1/drugs/61d853dd-77c0-4215-b3ba-1c5149e470b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań lub infuzji w ampułko-strzykawce",
"source": "urpl",
"strength": "30 mln j./0,5 ml",
"packaging": "Rpz ¦ EU/1/14/946/001 ¦ 104778\n1 amp.-strzyk. 0,5 ml ¦ 1 wacik nasączony alkoholem\nRpz ¦ EU/1/14/946/002 ¦ 104779\n5 amp.-strzyk. 0,5 ml ¦ 5 wacików nasączonych alkoholem\n05055565713860 ¦ Rpz ¦ EU/1/14/946/008 ¦ 118869\n5 amp.-strzyk. 0,5 ml (w blistrze) ¦ 5 wacików nasączonych alkoholem\n05055565713846 ¦ Rpz ¦ EU/1/14/946/005 ¦ 118870\n1 amp.-strzyk. 0,5 ml (w blistrze) ¦ 1 wacik nasączony alkoholem\nRpz ¦ EU/1/14/946/006 ¦ 118871\n3 amp.-strzyk. 0,5 ml ¦ 3 waciki nasączone alkoholem\nRpz ¦ EU/1/14/946/007 ¦ 118872\n3 amp.-strzyk. 0,5 ml (w blistrze) ¦ 3 waciki nasączone alkoholem\n05055565726068 ¦ Rpz ¦ EU/1/14/946/017 ¦ 118873\n7 amp.-strzyk. 0,5 ml (w blistrze) ¦ 7 wacików nasączonych alkoholem\nRpz ¦ EU/1/14/946/009 ¦ 118874\n10 amp.-strzyk. 0,5 ml ¦ 10 wacików nasączonych alkoholem\nRpz ¦ EU/1/14/946/010 ¦ 118875\n10 amp.-strzyk. 0,5 ml (w blistrze) ¦ 10 wacików nasączonych alkoholem",
"substance": "Filgrastimum 30 mln j./0,5 ml",
"common_name": "Filgrastimum",
"pl_product_id": "100327318",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about filgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.